Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan?

Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan?

Mylan Pharmaceuticals’ price hike scandal over the EpiPen--the device used by millions of Americans with severe, life-threatening allergies--has had consequences. The firm lost more than 25% of its share in the epinephrine auto...

Read more: fortune.com

Could Senate health care bill make opioid crisis 'worse'?

During a contentious interview with CNN, Kellyanne Conway said Friday that the news media needs to cover the nation's opioid crisis more, and she beat back at suggestions that the new health care bill does nothing to improve...

Data Sheet—Saturday, June 24, 2017

A lesson to be drawn from my feature, published Friday, on Google’s Project Zero, the search giant’s elite computer bug hunting squad, is: You can do everything in your power to make sure your digital defenses are up to snuff,...

Google’s Elite Project Zero Hackers Teach Business a Lesson

A lesson to be drawn from my feature, published Friday, on Google’s Project Zero, the search giant’s elite computer bug hunting squad, is: You can do everything in your power to make sure your digital defenses are up to snuff,...

Costco Stock Suffers Massive Slide after Amazon-Whole Foods Deal

It's a bad time to be in the grocery business, or anywhere near it. That, at least, was the message markets sent Costco this week, as the bulk retailer's stock took a vertiginous 12.7% drop in the week leading up to...

Pirates Hit With $15 Million in Damages For Stealing Research Papers

Dutch academic publisher Elsevier has been awarded $15 million in damages in a suit against Sci-Hub and LibGen, two portals that make academic research available online for free. The judgment was made in a New York district court...